Physician, Chairman Pharmacy and Therapeutics
Oncology
Dr. Ian D. Schnadig, MD
|
|
Give Review
Schnadig is an expert in the field of Oncology. He went to Rush Medical College. He has 1 awards "Meaningful Use Stage 1 Certification". Dr. Ian D. Schnadig is a published doctor and has 11 publications published. The lastest was: 'Treatment of CD30-positive systemic mastocytosis with brentuximab vedotin.' Schnadig accepts Medicare.
Publications
- Efficacy and safety of rolapitant for prevention of chemotherapy-induced nausea and vomiting over multiple cycles of moderately or highly emetogenic chemotherapy.
- Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting after administration of moderately emetogenic chemotherapy or anthracyclin...
- Safety and efficacy of rolapitant for prevention of chemotherapy-induced nausea and vomiting after administration of cisplatin-based highly emetogenic chemotherapy in ...
- Clinical outcomes with bevacizumab-containing and non-bevacizumab-containing regimens in patients with recurrent glioblastoma from US community practices.
- Dosing Patterns, Toxicity, and Outcomes in Patients Treated With First-Line Sunitinib for Advanced Renal Cell Carcinoma in Community-Based Practices.
- Light Chain Renal Amyloidosis With Prominent Giant Cells.
- Optimal timing of chemotherapy in androgen independent prostate Cancer.
- Patient-physician disagreement regarding performance status is associated with worse survivorship in patients with advanced Cancer.
- Gastrointestinal stromal tumors: imatinib and beyond.
- Treatment of CD30-positive Systemic mastocytosis with brentuximab vedotin.
Schools
Rush Medical College Of Rush University
Oregon Health Sciences University
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
- Urologic Oncology
Accepted Insurances
Awards
- Meaningful Use Stage 1 Certification
Education
-
Oregon Health & Science University -
Rush Medical College
Hospital
-
Providence St. Vincent Medical Center
Drug Facts
| NPI NUMBER | 1467664839 | |
| NPPES Provider LastName | SCHNADIG | |
| NPPES Provider FirstName | IAN | |
| NPPES Provider ZIPCode | 970625701 | |
| NPPES Provider State | OR | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 572.0 | |
| Distinct Opioid Count | 3.0 | |
| Opioid Claim Count | 68.0 | |
| Percent Opioid Claims | 11.89 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1467664839 |
| Last Name Of The Provider | SCHNADIG |
| First Name Of The Provider | IAN |
| View All |
Similar Doctors
|
Dr. Christopher J. Nogeire, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Kathleen L. Fielder, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Huan T. Ha, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Kevin D. Olson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Frederick S. Ey, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Christopher A. Yasenchak, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charles H. Doolittle III, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kelly S. Perlewitz, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Edward H. Chang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeffrey E. McWilliams, MD
This Doctor is OpenDoctor Recommended.
|